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While modern toxicology has focused on
understanding biological mechanisms
involved in the expression of toxicity at
the molecular level, a technological revo-
lution has occurred enabling researchers
to perform experiments on a scale of
unprecedented proportions (Marshall and
Hodgson 1998; Ramsay 1998). High-
throughput experimentation is producing
large amounts of data impossible to analyze
without informatics-related support
(Bellenson 1999; Spengler 2000). We see a
paradigm shift in toxicology research,
where hypothesis-driven research is com-
plemented by data-driven experimentation
designed to be hypothesis generating
(Afshari et al. 1999). Although toxicoge-
nomics, the study of toxicology using high-
throughput “omics” technologies (Aardema
and MacGregor 2002; Hamadeh et al.
2002; Nuwaysir et al. 1999; Schmidt 2002;
Ulrich and Friend 2002), and systems toxi-
cology, the study of toxicology through
data integration (Waters et al. 2003), have
advanced rapidly and are likely to continue
to advance, development of software
infrastructures to manage, analyze, and
integrate the diverse data has lagged
behind. Recently, Waters et al. (2003) pro-
posed a conceptual framework of chemical
effects in biological systems [(CEBS)
Chemical Effects in Biological Systems
knowledge base] to meet the expanding
toxicogenomic research needs at the
National Center for Toxicogenomics
(NCT) (Tennant 2002), including both
NCT intramural research and research
within the Toxicogenomics Research
Consortium (TRC) (Medlin 2002). Both
the NCT and the TRC are located at the
National Institute of Environmental
Health Sciences (NIEHS) in the Research
Triangle Park, North Carolina.
Implementing toxicogenomic technolo-
gies is a high-priority initiative at the U.S.
Food and Drug Administration (U.S. FDA)
National Center for Toxicological Research
(NCTR). A microarray core facility using
validated and standardized protocols has
been established. Similar facilities for
proteomics and metabonomics are at an
advanced stage of development and are
preparing for validation of protocols. A
toxicoinformatics integrated system (TIS) is
concurrently being developed to meet the
data management and analysis challenges
associated with these efforts. The TIS is
designed to aggregate data from toxico-
genomic research with traditional toxico-
logical end points and chemical data, along
with sequence, gene function, and pathway
data in public repositories. Through inte-
gration of different data types with analysis
capabilities, the TIS will enable extraction
of a tailored data set for data interpretation
and hypothesis generation and testing. 
In this article, the prototype of TIS,
ArrayTrack, is presented in the context of
meeting the following bioinformatics chal-
lenges associated with DNA microarray
experiments in toxicology:
• How to manage the massive information
associated with a microarray experiment
and determine what relevant toxicology-
specific experimental information or
ontology needs to be acquired for the
database. 
•W hat visualization and analysis capabili-
ties are required to efficiently extract
knowledge from the microarray data.
•H ow the microarray experimental data
should be linked with data from public
databases to make the germane informa-
tion on gene annotation, protein func-
tion, and pathways readily available for
data interpretation. 
Methods
ArrayTrack contains three integrated
components: a) MicroarrayDB, which
stores essential data associated with a
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The mapping of the human genome and the determination of corresponding gene functions,
pathways, and biological mechanisms are driving the emergence of the new research fields of
toxicogenomics and systems toxicology. Many technological advances such as microarrays are
enabling this paradigm shift that indicates an unprecedented advancement in the methods of
understanding the expression of toxicity at the molecular level. At the National Center for
Toxicological Research (NCTR) of the U.S. Food and Drug Administration, core facilities for
genomic, proteomic, and metabonomic technologies have been established that use standardized
experimental procedures to support centerwide toxicogenomic research. Collectively, these facilities
are continuously producing an unprecedented volume of data. NCTR plans to develop a toxico-
informatics integrated system (TIS) for the purpose of fully integrating genomic, proteomic, and
metabonomic data with the data in public repositories as well as conventional in vitro and in vivo
toxicology data. The TIS will enable data curation in accordance with standard ontology and pro-
vide or interface a rich collection of tools for data analysis and knowledge mining. In this article
the design, practical issues, and functions of the TIS are discussed through presenting its proto-
type version, ArrayTrack, for the management and analysis of DNA microarray data. ArrayTrack
is logically constructed of three linked components: a) a library (LIB) that mirrors critical data in
public databases; b) a database (MicroarrayDB) that stores microarray experiment information
that is Minimal Information About a Microarray Experiment (MIAME) compliant; and c) tools
(TOOL) that operate on experimental and public data for knowledge discovery. Using
ArrayTrack, we can select an analysis method from the TOOL and apply the method to selected
microarray data stored in the MicroarrayDB; the analysis results can be linked directly to gene
information in the LIB. Key words: bioinformatics, data analysis, database, genomics, infrastruc-
ture, MIAME, microarray, systems toxicology, toxicogenomics, toxicology. Environ Health
Perspect 111:1819–1826 (2003). doi:10.1289/txg.6497 available via http://dx.doi.org/ [Online
15 September 2003]
Toxicogenomics Commentarymicroarray experiment, including informa-
tion on slide samples, treatment, and exper-
imental results; b) TOOL, which provides
analysis capabilities for data visualization,
normalization, signiﬁcance analysis, cluster-
ing, and classification; and c) LIB, which
contains information from public reposito-
ries (e.g., gene annotation, protein function,
and pathways). MicroarrayDB and LIB are
used to store in-house experimental results
and public data, respectively, whereas
TOOL provides various algorithms for data
visualization and analysis. At the time of
this writing, ArrayTrack is not open-source
software but can be accessed through the
World Wide Web (http://edkb.fda.gov/
webstart/arraytrack/). Prospective users can
also acquire the software free of charge by
contacting the authors.
Both MicroarrayDB and LIB were
developed based on the Oracle relational
database management system (Oracle
Corp., Redwood Shores, CA). The data-
base structure of MicroarrayDB and LIB
was designed to accommodate the essential
data associated with a microarray experi-
ment as well as the data from the public
repositories on genes, proteins, and path-
ways (database schema available upon
request). The robust design allows data
entities (tables of the identical type of data)
and their relationships in the databases to
be conveniently added and modified to
accommodate needs of ever-evolving
microarray technology and public data-
bases. The diverse data in MicroarrayDB
and LIB are stored in an IBM storage area
network (SAN), and backed up daily using
TSM (the Tivoli storage manager system). 
User interface components providing
query analysis and visualization capabilities
are programmed in the Java language,
ensuring portability to most computer
operating systems as well as enabling easy
Web deployment. Interfaces have been
built for several data exchange formats,
including flat text files and Microsoft
Ofﬁce Excel spreadsheets (Microsoft Corp.,
Redmond, WA). The “data drilling”
capabilities were developed to allow the
user to lock down and requery the database
across other data within the realm of the
previous query. 
Controlling access to experimental data
is a sensitive issue for many organizations
and researchers. ArrayTrack allows only the
owner of the data and members of groups
approved by the owner to access the data to
either read or write. 
Results
Figure 1 depicts the ArrayTrack com-
prising three integrated components:
a)M icroarrayDB, b) TOOL, and c) LIB.
Through a user-friendly interface, the user
can select an analysis method from the
TOOL, apply the method to selected
microarray data stored in the MicroarrayDB,
and link the analysis results directly to gene
information in the LIB. Additionally,
ArrayTrack also allows data to be directly
linked with other public databases.
MicroarrayDB
Microarray experimentation is one of the
fastest-growing methods used in genomic
research and has led to a broad diversity
of microarray databases in both the
public domain and commercial domains
(Gardiner-Garden and Littlejohn 2001).
Unfortunately, most if not all of them fail
to accommodate the toxicology-related
information needed for toxicogenomic
studies. Recently, a joint effort between
International Life Sciences Institute’s
Health and Environmental Sciences
Institutes (ILSI HESI), NIEHS-NCT; and
European Molecular Biology Laboratory–
European Bioinformatics Institute (EMBL-
EBI) resulted in a draft deﬁning the required
information for toxicogenomic experiments.
Augmenting the original Minimum
Information about a Microarray Experiment
(MIAME; http://www.mged.org) proposal
(Brazma et al. 2001), the MIAME/Tox doc-
ument outlines the minimum information
required for a toxicogenomic experiment to
ensure that the results are interpretable and
the experiment is replicable.
Our goal is to develop a validated
microarray database as a rich resource for
cross-experiment and platform comparison
to derive toxicity-specific signatures. By
validated, we mean that data are stored if
and only if they meet prescribed standards
for completeness and accuracy as well as
conformance to the applicable ontology.
MicroarrayDB was designed to support
toxicogenomic studies adhering to the
MIAME guidelines. Currently, a number
of journals, including Nature, the Nature
group of journals, Cell, The Lancet, EMBO,
and Toxicology Pathology, require an acces-
sion number from the public microarray
databases developed based on the MIAME
guidelines, which must be supplied on
or before acceptance of publication
(Anonymous 2002; Ball et al. 2002). The
following practical issues were specifically
discussed for implementing the MIAME
guidelines among software developers,
bioinformaticians, and toxicologists who
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Figure 1. Overall system architecture of ArrayTrack. The software consists of three integrated compo-
nents: MicroarrayDB captures toxicogenomic data associated with a microarray experiment; TOOL pro-
vides data visualization and analysis capabilities; and LIB contains annotated information on genes,
proteins, and pathways.work closely together to understand
both the structure of the database and the
structure of the data to be stored in the
database:
• MIAME versus database: MIAME speci-
fies the content of the information to be
available, whereas the database addresses
how the content should be managed, and
most importantly, queried. In other
words, there is a distinction between the
way the database handles all available
information and a subset that is search-
able. Technically, both available and
searchable information can be treated in
the same way. However, practically, such
an approach usually imposes an inevitable
burden on the end user to enter all infor-
mation into the database in a tedious way,
which might hinder their participation.
Therefore, it is critical to deﬁne a balance
point that can be accepted by both experi-
mentalists and bioinformaticians.
• Local versus global repository: The
MIAME guidelines broadly specify
required data with the goal of a truly
global repository for public data deposi-
tion and data exchange that would
evolve as needs change. However, most
databases similar to ArrayTrack are
intended primarily, at least initially, for
local use within an institution. For local
institutional use, the extensive MIAME
format can be simplified while still
retaining essential information for toxi-
cogenomics experiment interpretation
and replication. 
Thus, the ArrayTrack is MIAME-
compliant, with inclusion of additional
parameters related to toxicogenomics,
using controlled vocabularies. Figure 2
gives the data submission requirements for
essential information from both the
microarray and toxicology perspectives.
Currently, MicroarrayDB contains over
650 array data. We are closely following
the current development of MicroArray
Gene Expression Markup Language
(MAGE-ML) standards (Spellman et al.
2002) that represent microarray data using
markup language. We will develop a mean
using MAGE-ML—an XML-based data
exchange format—to allow data in
MicroarrayDB to be communicated with
other microarray data repositories such as
ArrayExpress (http://www.ebi.ac.uk/array-
express; Brazma et al. 2003) and the Gene
Expression Omnibus (GEO; http://www.
ncbi.nlm.nih.gov/geo; Edgar et al. 2002).
LIB
The public domain has a rich and diverse
collection of biological databases that
greatly facilitates microarray experiment
interpretation and associated knowledge
discovery (Baxevanis 2003). A comprehen-
sive summary of the major databases can be
found in a special issue of Nucleic Acids
Research (2003). The databases we find
most valuable for microarray research are
GenBank (http://www.ncbi.nlm.nih.gov/;
Benson et al. 2003), SWISS-PROT
(http://www.expasy.org/sprot/ and http://
www.ebi.ac.uk/swissprot/; Boeckmann et
al. 2003); LocusLink (www.ncbi.nlm.nih.
gov/LocusLink; Kanehisa 2002); Kyoto
Encyclopedia of Genes and Genomes
(KEGG; http://www.genome.ad.jp/kegg/;
Kanehisa 2002); and Gene Ontology (GO;
http://www.godatabase.org/dev/database/;
Ashburner et al. 2000), each of which
emphasizes a different type or aspect of
biological information. ArrayTrack’s LIB is
a compilation of the essential public data to
facilitate annotation and interpretation of
microarray expression data. 
We downloaded a number of public
databases to create local mirrored databases
that are automatically updated every
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Figure 2. Data submission form. The form (A) consists of two sequential components: (1) “Experiment Design” and (2) “Hybridization and Data.” The description of
an experiment and its associated experimental protocols are input in the section “Experiment Design,” where the owner of the experiment can define “read
and/or write” privilege (B) to share the experiment with collaborators. The content and output of the experiment are input in the section “Hybridization and Data.”
The experiment details on the sample preparation can be input through this section (C).Toxicogenomics | Tong et al.
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.2 weeks using scripts. The LIB was the
selected aggregation of the information
in the mirrored databases that was relevant
for interpretation of microarray results.
Currently, the LIB comprises three sub-
libraries, GeneLib, ProteinLib, and
PathwayLib, which concentrate public data
on genes, proteins, and pathways, respec-
tively. Each contains only the most relevant
selected information from UniGene
(http://www.ncbi.nlm.nih.gov/UniGene/),
LocusLink, SWISS-PROT, KEGG,
and GO.
The three libraries (GeneLib, ProteinLib,
and PathwayLib) have the same design and
functional interface. A screen shot of the
GeneLib is displayed in Figure 3. The gene
information is displayed in an Excel-like
spreadsheet. Each row is associated with a
gene, and each column is a particular func-
tional annotation, such as chromosomal
location, pathway, or functional assignment
(molecular function, biological process,
and cellular component) defined by GO
(Ashburner et al. 2000). The spreadsheet
can be customized by including/excluding a
specific functional annotation. The com-
mon functions such as sorting, ranking, and
querying are available for comparison across
the entire gene list. The genes can also be
categorized on the basis of their common
pathways (Figure 4). In addition, detailed
information on each gene is available,
including synonym, sequence, chromoso-
mal map, and reference. Information for
genes not contained in the GeneLib is read-
ily available by hot link to a wide range of
public data repositories. 
Toxicogenomics | Tong et al.
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Figure 5. Quality control interface summarizes most relevant information into one interface to facilitate
the process of quality control of a microarray experiment. The tool allows investigator(s) to make a QC/QA
decision (F) for a slide using the following information: (A) the Cy3 versus Cy5 plot; (B) the rank intensity
plot of Cy3 and Cy5; (C) the slide image; (D) the summary of various statistics; and (E) the experimental
annotation.
Figure 6. ScatterPlot viewer. The function plots gene expression proﬁles of one sample versus another sample (A). The information on any gene circled in the plot
(A) will be displayed in the GeneLib (B).TOOL
The TOOL was designed to provide a
spectrum of algorithmic tools for microar-
ray data visualization, quality control, nor-
malization, significant gene identification,
pattern discovery, and class prediction. 
A quality assurance/quality control tool
was developed to assist quality control of
slide array results (Figure 5). The tool sum-
marizes most relevant information into one
interface to facilitate the process of quality
control. The user can determine the quality
of individual microarray results through
visualizing data, applying statistical meas-
ures, and viewing experimental annotation.
Statistical measures are provided to assess
the quality of a hybridization result based on
the raw expression data, including signal-to-
noise ratio, the percentage of nonhybridized
spots, etc. The experimental annotations
associated with the processes of hybridiza-
tion, RNA extraction, and labeling are also
available to the end user. Additionally, a
scatterplot of Cy3 versus Cy5, together with
the original image, is available for visual
inspection for quality control purposes. 
Two data visualization methods are
currently provided—ScatterPlot Viewer
and VirtualImage viewer. The ScatterPlot
viewer plots gene expression proﬁles of one
sample versus another sample (Figure 6),
whereas the VirtualImage viewer displays
expression pattern in an array image format
(Figure 7). Both functions permit visual
identification of significant genes and
hyperlink directly from the graph to addi-
tional detailed library information on any
particular gene.
Discussion
The GeneLib, ProteinLib, and PathwayLib
components of ArrayTrack contain general
but essential information for functional
genomics research. These libraries also pro-
vide a basis for linking and integrating vari-
ous omics data. For example, lists of genes,
proteins, and metabolites derived from vari-
ous omics platforms could be cross-linked
based on their common identiﬁers through
these three libraries. An additional library,
ToxicantLib, is being developed for
ArrayTrack and will similarly provide link-
age between toxicological data and the dif-
ferent types of omics data. The ToxicantLib
contains the chemical name and structure
together with toxicological end points.
Through the similarity comparison of the
chemical structure of a toxicant with the
structures of the metabolites in the
PathwayLib, we might be able to examine
the toxicity effect of a particular toxicant at
the molecular level. The first toxicological
data in ToxicantLib are data from our
endocrine disruptor knowledge base
(EDKB; http://edkb.fda.gov/; Tong et al.
2002) and the carcinogenicity potency
database (CPDB) (Gold and Zeiger 1997).
Other specific toxicology libraries will be
added in the near future, including LiverLib
(gene/protein associated with liver toxicity)
and SNPsLib (containing information on
single-nucleotide polymorphism). 
Development of commercial software for
visualizing and analyzing microarray data is
currently an area of vigorous effort by bioin-
formatics-oriented companies. Representative
software providers for microarray data analy-
sis include Spotfire, Silicon Genetics,
BioDiscovery , and Partek. Similarly, a diver-
sity of software is available in the public
domain, some of which can be accessed
through a website at Stanford University
(http://genome-www.stanford.edu/).
Collectively, commercial and public software
Toxicogenomics | ArrayTrack—supporting toxicogenomic research at the U.S. FDA NCTR
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Figure 7. VirtualArray viewer. The function shows a reconstruction of the original array image from the expression data derived from the array (A). This virtual
array image provides a visual representation of data in the format of the original image. There are several functions on the top of the image that allow browsing
the contents of the array, identifying signiﬁcant spots and information about their corresponding genes. For example, there are two sliding controls for ﬁltering
out unwanted spots. The upper sliding control is used to eliminate spots whose expression fold change is less than the predeﬁned criteria. The other sliding con-
trol is used to eliminate spots for which the intensity of both Cy3 and Cy5 channels falls below the selected threshold. The resulting image (B) contains only those
genes that meet both ratio and intensity criteria. Those genes can be directly linked to the GeneLib.provide many redundant capabilities, though
particular software may have unique features
or other attributes or familiarity that appeal
to end users. Consequently, we have devel-
oped and will develop more interfaces (as
part of TOOL) to provide interoperability
between ArrayTrack and other analysis soft-
ware. ArrayTrack includes some tools com-
mon to other bioinformatics software, but
future development will focus on novel
analysis approaches and tools for toxicology-
specific problems. For example, we devel-
oped a novel class prediction method,
heterogeneous decision forest (Tong et al.
2003), that could be useful for omics data
analysis generally and for development of
predictive models in particular. 
ArrayTrack has been developed and
programmed in a modular manner and
uses a Java library such that the code is
readily extensible for other omics data,
such as proteomics and metabonomics, as
well as for conventional toxicology data.
The extended system, supporting the
diversity of data types, is the TIS, which
will be under further development and
evolution for several more years. The ulti-
mate goal is for TIS to serve as a general,
broad repository for diverse data sources
(e.g., omics, toxicology, and chemical
structure data), supporting broad data
mining and meta-analysis activities as well
as development of robust and validated
predictive systems. The TIS will facilitate
scientific discovery and productivity via
effective management of diverse data and
knowledge and by integration of toxico-
logical information at different levels of
biological complexity. Through cross-link-
ing gene, protein, and pathway informa-
tion available in public databases, and
experimental data from multiple experi-
ments, protocols, and labs, systems toxi-
cology will allow a fuller understanding of
toxicological mechanisms. 
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